FFA
LPCN icon

Farther Finance Advisors’s Lipocine LPCN Stock Holding History

Farther Finance Advisors’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3 Hold
1
– – ﹤0.01% 5954
2026
Q1 		$9 Buy
+1
New +$9 ﹤0.01% 5694

Other funds holding LPCN

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

Farther Finance Advisors's LPCN Position: Q2 2026 in Review

Farther Finance Advisors held its Lipocine (LPCN) position steady in Q2 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #5954.

Farther Finance Advisors first reported a position in LPCN in Q1 2026 and has held it in 2 quarters since. The position peaked at $9 in Q1 2026. 3 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • Farther Finance Advisors held 1 share of Lipocine worth $3 as of Q2 2026.
  • Farther Finance Advisors left its Lipocine share count unchanged in Q2 2026.
  • Lipocine made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5954 holding.
  • Farther Finance Advisors first reported a position in Lipocine in Q1 2026 and has held it in 2 quarters since.
  • Farther Finance Advisors's Lipocine position peaked at $9 in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.